Skip to main content
SpringerLink
Log in

Epidemiology of COPD: Why Is the Disease So Poorly Recognized?

  • Chapter
  • First Online:
Chronic Obstructive Pulmonary Disease

Abstract

COPD is currently ranked third in the cause of death around the world. The habit of smoking cigarettes is obviously related to occurrence of COPD, and many cases of COPD are caused by heavy cigarette smoking. However, besides cigarette smoking, occupational exposure to airborne particulates and pollutants are also known to be risk factors for developing COPD. Particularly, the indoor use of biomass fuel has been pointed out as one of the major risk factors for the occurrence COPD in developing countries. COPD develops after a long period of exposure to cigarette smoke; thus, it is characterized by a gradual progression of symptoms. Many patients are not diagnosed with COPD until their symptoms have considerably worsened or acute exacerbation due to respiratory inflammation. Health damage by COPD has a great impact on society as well as on the individual patient; hence, it is important to make a diagnosis early and prevent patients from exposure to risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–85.

    Article  CAS  PubMed  Google Scholar 

  2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180:3–10.

    Article  PubMed  Google Scholar 

  4. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.

    Article  CAS  PubMed  Google Scholar 

  5. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.

    Article  PubMed  Google Scholar 

  6. Osaka D, Shibata Y, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Sato M, Kishi H, Takabatake N, Sata M, Watanabe T, Konta T, Kawata S, Kato T, Kubota I. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study. Intern Med. 2010;49:1489–99.

    Article  PubMed  Google Scholar 

  7. Todd JL, Goldstein DB, Ge D, Christie J, Palmer SM. The state of genome-wide association studies in pulmonary disease: a new perspective. Am J Respir Crit Care Med. 2011;184:873–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc. 2007;4:512–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nakano H, Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Sato M, Aida Y, Nunomiya K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I. Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata Study. PLoS One. 2013;8, e81678.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hulin M, Simoni M, Viegi G, Annesi-Maesano I. Respiratory health and indoor air pollutants based on quantitative exposure assessments. Eur Respir J. 2012;40:1033–45.

    Article  CAS  PubMed  Google Scholar 

  11. Laumbach RJ, Kipen HM. Respiratory health effects of air pollution: update on biomass smoke and traffic pollution. J Allergy Clin Immunol. 2012;129:3–11; quiz 12–13.

    Google Scholar 

  12. Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010;138:20–31.

    Article  PubMed  Google Scholar 

  13. Diette GB, Accinelli RA, Balmes JR, Buist AS, Checkley W, Garbe P, Hansel NN, Kapil V, Gordon S, Lagat DK, Yip F, Mortimer K, Perez-Padilla R, Roth C, Schwaninger JM, Punturieri A, Kiley J. Obstructive lung disease and exposure to burning biomass fuel in the indoor environment. Glob Heart. 2012;7:265–70.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Jordan RE, Cheng KK, Miller MR, Adab P. Passive smoking and chronic obstructive pulmonary disease: cross-sectional analysis of data from the Health Survey for England. BMJ Open. 2011;1, e000153.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hagstad S, Bjerg A, Ekerljung L, Backman H, Lindberg A, Ronmark E, Lundback B. Passive smoking exposure is associated with increased risk of COPD in never-smokers. Chest. 2013;145(6):1298–304.

    Article  Google Scholar 

  16. Ko FW, Hui DS. Air pollution and chronic obstructive pulmonary disease. Respirology. 2012;17:395–401.

    Article  PubMed  Google Scholar 

  17. Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med. 2013;187:721–7.

    Article  PubMed  Google Scholar 

  18. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543–54.

    Article  CAS  PubMed  Google Scholar 

  19. Mohamed Hoesein FA, Zanen P, Boezen HM, Groen HJ, van Ginneken B, de Jong PA, Postma DS, Lammers JW. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest. 2012;142:1530–8.

    Article  PubMed  Google Scholar 

  20. Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185:1301–6.

    Article  PubMed  Google Scholar 

  21. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185:44–52.

    Article  PubMed  Google Scholar 

  22. Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373:111–22.

    Article  CAS  PubMed  Google Scholar 

  23. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457–94.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kojima S, Sakakibara H, Motani S, Hirose K, Mizuno F, Ochiai M, Hashimoto S. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol. 2007;17:54–60.

    Article  PubMed  Google Scholar 

  25. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.

    Article  PubMed  Google Scholar 

  26. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–50.

    Article  PubMed  Google Scholar 

  27. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9:458–65.

    Article  PubMed  Google Scholar 

  28. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160:1683–9.

    Article  CAS  PubMed  Google Scholar 

  29. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, Garcia-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, Gonzalez-Garcia M, Buist S. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–85.

    Article  PubMed  Google Scholar 

  30. Decramer M, Cooper CB. Treatment of COPD: the sooner the better? Thorax. 2010;65:837–41.

    Article  PubMed  Google Scholar 

  31. Santos SR, Lizzi ES, Vianna EO. Characteristics of undiagnosed COPD in a senior community center. Int J Chron Obstruct Pulmon Dis. 2014;9:1155–61.

    PubMed  PubMed Central  Google Scholar 

  32. Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodriguez E, Benet M, Farrero E, Ferrer A, Guerra S, Ferrer J, Sauleda J, Barbera JA, Agusti A, Rodriguez-Roisin R, Gea J, Anto JM, Garcia-Aymerich J. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15:4.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233–9.

    Article  PubMed  Google Scholar 

  34. Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, Nemoto T, Kimura T, Watanabe T, Konta T, Daimon M, Ueno Y, Kato T, Kayama T, Kubota I. A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One. 2013;8, e83725.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata City, Yamagata, 990-9585, Japan

    Yoko Shibata

Authors
  1. Yoko Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoko Shibata .

Editor information

Editors and Affiliations

  1. Department of Respiratory Medicine, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan

    Hiroyuki Nakamura

  2. Department of Respiratory Medicine, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan

    Kazutetsu Aoshiba

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Shibata, Y. (2017). Epidemiology of COPD: Why Is the Disease So Poorly Recognized?. In: Nakamura, H., Aoshiba, K. (eds) Chronic Obstructive Pulmonary Disease. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-10-0839-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-0839-9_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-0838-2

  • Online ISBN: 978-981-10-0839-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation